Silvia Masera

757 total citations
10 papers, 505 citations indexed

About

Silvia Masera is a scholar working on Pathology and Forensic Medicine, Neurology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Silvia Masera has authored 10 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Silvia Masera's work include Multiple Sclerosis Research Studies (6 papers), Alzheimer's disease research and treatments (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Silvia Masera is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Alzheimer's disease research and treatments (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Silvia Masera collaborates with scholars based in Italy, Argentina and United States. Silvia Masera's co-authors include Marco Vercellino, Paola Cavalla, Alessandra Mattioda, Roberto Mutani, Aristide Merola, Elisabetta Capello, Gianluigi Mancardi, Maria Teresa Giordana, Antonella Tribolo and Cecilia Condello and has published in prestigious journals such as Journal of Neuropathology & Experimental Neurology, Toxicon and Multiple Sclerosis Journal.

In The Last Decade

Silvia Masera

10 papers receiving 496 citations

Peers

Silvia Masera

PFM

NEURO

IMMUN

PHEOH

NEURO

Valeria Barletta Italy

D. Farina Italy

Anton Vladić Croatia

Nuhad Abou Zeid United States

Simona Toscano Italy

J Scott Sloka Canada

C. Smestad Norway

Jitesh Rana United States

Marco Puthenparampil Italy

K. Kapinas Greece

Valeria Barletta Italy

Silvia Masera

327 ×0.9

PFM

77 ×0.6

NEURO

77 ×0.7

IMMUN

30 ×0.4

PHEOH

42 ×0.6

NEURO

Citations per year, relative to Silvia Masera Silvia Masera (= 1×) peers Valeria Barletta

Countries citing papers authored by Silvia Masera

Since Specialization

Citations

This map shows the geographic impact of Silvia Masera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Masera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Masera more than expected).

Fields of papers citing papers by Silvia Masera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Masera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Masera. The network helps show where Silvia Masera may publish in the future.

Co-authorship network of co-authors of Silvia Masera

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Masera. A scholar is included among the top collaborators of Silvia Masera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Masera. Silvia Masera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Moccia, Marcello, Ilaria Loperto, Silvia Masera, et al.. (2022). Healthcare Resource Utilization and Costs for Extended Interval Dosing of Natalizumab in Multiple Sclerosis. Neurodegenerative Disease Management. 12(3). 109–116. 9 indexed citations

Cortesi, Paolo Angelo, et al.. (2020). PDG15 Evolution of Natalizumab Use in Two Italian Multiple Sclerosis Centers. Value in Health. 23. S523–S523. 1 indexed citations

Capra, Ruggero, Vincenzo Brescia Morra, Massimiliano Mirabella, et al.. (2020). Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results. Neurological Sciences. 42(7). 2837–2845. 14 indexed citations

Masera, Silvia, Paola Cavalla, Luca Prosperini, et al.. (2014). Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis. Multiple Sclerosis Journal. 21(10). 1291–1297. 40 indexed citations

Vercellino, Marco, Silvia Grifoni, Alberto Romagnolo, et al.. (2011). Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis. Multiple Sclerosis Journal. 17(10). 1194–1201. 47 indexed citations

Vercellino, Marco, Silvia Masera, Cecilia Condello, et al.. (2009). Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter. Journal of Neuropathology & Experimental Neurology. 68(5). 489–502. 219 indexed citations

Vercellino, Marco, Alberto Romagnolo, Alessandra Mattioda, et al.. (2008). Multiple sclerosis relapses: a multivariable analysis of residual disability determinants. Acta Neurologica Scandinavica. 119(2). 126–130. 45 indexed citations

Andrinolo, Darı́o, Daniela Sedán, Claudia Aura, et al.. (2007). Hepatic recovery after damage produced by sub-chronic intoxication with the cyanotoxin microcystin LR. Toxicon. 51(3). 457–467. 35 indexed citations

Cavalla, Paola, Silvia Masera, Marco Vercellino, et al.. (2006). Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurological Sciences. 27(4). 231–239. 94 indexed citations

10.

Vercellino, Marco, Paola Cavalla, Barbara Votta, et al.. (2005). Neuronal and synaptic pathology in the demyelinating lesions of grey matter in multiple sclerosis. Clinical Neuropathology. 24. 152–153. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact